Bristol Myers Squibb
Bristol Myers Squibb's Overview
Bristol Myers Squibb is a leading global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. With a focus on areas of high unmet medical need, BMS is at the forefront of scientific innovation in oncology, hematology, immunology, cardiovascular disease, and neuroscience. The company combines the agility of biotech with the reach and resources of a major pharmaceutical enterprise to bring transformative therapies to patients worldwide.
Where is Bristol Myers Squibb's Headquarters?
HQ Function
Serves as the primary hub for corporate strategy, global management, executive leadership, R&D oversight, and key administrative functions, supporting worldwide research, development, and commercial operations.
Notable Features:
The Princeton and Lawrenceville campuses feature state-of-the-art research laboratories, modern office spaces designed for collaboration, advanced manufacturing capabilities (in the broader NJ footprint), and employee amenities, reflecting a commitment to scientific advancement and a supportive work environment.
Work Culture:
The work culture at BMS's New Jersey sites is characterized by a strong emphasis on scientific innovation, cross-functional collaboration, a patient-centric mission, and a commitment to diversity, inclusion, and ethical practices. Employees often describe it as dynamic, purpose-driven, and focused on transformative science.
HQ Significance:
The New Jersey headquarters and major campuses are strategically significant, positioning BMS within a major pharmaceutical and biotechnology corridor. This facilitates access to top talent, renowned research institutions, and industry partners, underscoring the company's long-standing presence and investment in the region as a hub for biopharmaceutical innovation.
Values Reflected in HQ: The headquarters' environment and operations aim to reflect BMS's core values: innovation, passion for patients, scientific excellence, integrity, inclusion, and urgency in discovering, developing, and delivering life-changing medicines.
Location:
Bristol Myers Squibb maintains a significant global presence, with operations spanning North America, South America, Europe, Asia, and Australia. This includes major research and development sites, state-of-the-art manufacturing facilities for biologics and pharmaceuticals, extensive clinical trial operations conducted in numerous countries, and commercial offices that ensure their innovative medicines reach patients worldwide. Their global infrastructure supports the full lifecycle of drug discovery, development, manufacturing, and commercialization.
Street Address:
100 Nassau Park Boulevard, Princeton Pike Corporate Center
City:
Princeton
State/Province:
New Jersey
Country:
USA
Bristol Myers Squibb's Global Presence
Redwood City, California, USA
Address: 900 Chesapeake Dr, Redwood City, CA 94063, USA
Serves as a critical hub for BMS's West Coast research and development presence, leveraging the dynamic San Francisco Bay Area biotech ecosystem to foster collaborations, attract talent, and drive innovation in immuno-oncology and other strategic therapeutic areas.
Cambridge, Massachusetts, USA
Address: 100 Binney St, Cambridge, MA 02142, USA
Positions BMS within the vibrant Cambridge/Boston biotech cluster, enabling close collaboration with leading academic institutions, research organizations, and biotech companies to accelerate scientific breakthroughs.
Uxbridge, United Kingdom
Address: Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH, UK
Acts as a key operational center for BMS in Europe, coordinating market access, product launches, and lifecycle management for its portfolio of innovative medicines in the region.
Buying Intent Signals for Bristol Myers Squibb
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Bristol Myers Squibb
As of April 2025, Bristol Myers Squibb' leadership includes:
Investors of Bristol Myers Squibb
Bristol Myers Squibb has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past year, Bristol Myers Squibb underwent a notable CEO transition with Christopher Boerner taking the helm and Giovanni Caforio moving to Executive Chairman. The company also appointed Adam Lenkowsky as its new Chief Commercialization Officer and saw the departure of Elizabeth Mily, EVP of Strategy & Business Development.
Departures
New Appointments:
Technology (Tech Stack) used by Bristol Myers Squibb
Discover the tools Bristol Myers Squibb uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Bristol Myers Squibb Email Formats and Examples
Bristol Myers Squibb primarily utilizes the 'firstname.lastname@bms.com' email format for its employees. While other formats might exist in isolated cases or for specific systems, this is the most common and reliable structure for professional communication.
firstname.lastname@bms.com
Format
jane.doe@bms.com
Example
95%
Success rate
News and media
Bristol Myers Squibb News • March 18, 2024
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio
Bristol Myers Squibb successfully finalized its acquisition of Karuna Therapeutics, Inc. for $14 billion. This strategic move enhances BMS's neuroscience pipeline with KarXT (xanomeline-trospium), a promising investigational medicine for schizophrenia and Alzheimer's disease psychosis....more
Bristol Myers Squibb News • February 26, 2024
Bristol Myers Squibb Completes Acquisition of RayzeBio
Bristol Myers Squibb announced the completion of its acquisition of RayzeBio, Inc. for approximately $4.1 billion. This acquisition expands BMS's oncology portfolio with RayzeBio's differentiated actinium-based radiopharmaceutical platform and pipeline of innovative cancer therapies....more
Bristol Myers Squibb News • March 14, 2024
U.S. FDA Approves Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) for First-Line Metastatic Urothelial Carcinoma
The FDA granted approval for Opdivo in combination with Yervoy for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma (mUC). This approval offers a new chemotherapy-free immunotherapy option for this patient population....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Bristol Myers Squibb, are just a search away.